Camilla Olaisen
St. Olavs Hospital
Trondheim, Norway
Trondheim, Norway
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
The dynamic Alp landscape of Streptococcus dysgalactiae.
Journal: Frontiers in cellular and infection microbiology
Published: December 18, 2025
Multiple Myeloma Cells with Increased Proteasomal and ER Stress Are Hypersensitive to ATX-101, an Experimental Peptide Drug Targeting PCNA.
Journal: Cancers
Published: October 29, 2024
Identification and characterisation of carbapenem-resistant Streptococcus nidrosiense sp. nov. isolated from blood culture.
Journal: New microbes and new infections
Published: June 10, 2024
Incidence of invasive infections with Group B streptococcus in adults in Norway 1996-2019: a nationwide registry-based case-control study.
Journal: Infection
Published: December 14, 2023
Quality assessment of LNP-RNA therapeutics with orthogonal analytical techniques.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: April 21, 2023
PCNA regulates primary metabolism by scaffolding metabolic enzymes.
Journal: Oncogene
Published: April 29, 2022
The Streptococcus agalactiae R3 surface protein is encoded by sar5.
Journal: PloS one
Published: January 07, 2022
On-column trypsinization allows for re-use of matrix in modified multiplexed inhibitor beads assay.
Journal: Analytical biochemistry
Published: December 06, 2016
PCNA-interacting peptides reduce Akt phosphorylation and TLR-mediated cytokine secretion suggesting a role of PCNA in cellular signaling.
Journal: Cellular signalling
Published: March 03, 2015
Last Updated: 09/26/2026